Practical Pediatric HematologyAnupam Sachdeva Evidence-based medicine is the need of the hour. Every pediatrician strives for perfection is his or her practice. These are exciting times for Pediatric Hematology and Oncology. Major advances during the past decade in the field have enhanced the understanding and significantly influenced the management and outcome of many of these chronic and fatal diseases affecting children. While opportunities to learn decrease after one leaves the medical school, science keeps evolving. Keeping this in mind, Indian Academy of Pediatrics (IAP) envisaged starting specialty training under its plan of action 2006. Such trainings keep professional and residents updated about newly launched technologies and other advancements. This book is well illustrated and has many pictures and diagrams for the quick understanding of readers. This will be of use not only to the postgraduates of pediatrics but also will be of immense use to a general pediatrician as a ready-reckoner to be kept on the desk. |
From inside the book
Page xix
... Prophylaxis Program 53 Evaluation of Iron Supplementation Program 53 National Nutritional Anemia Control Program 53 Aplastic Anemia: Current Issues in Diagnosis and Management 57 Bharat RAgarwal, Nivedita Dhingra Pancytopenia in ...
... Prophylaxis Program 53 Evaluation of Iron Supplementation Program 53 National Nutritional Anemia Control Program 53 Aplastic Anemia: Current Issues in Diagnosis and Management 57 Bharat RAgarwal, Nivedita Dhingra Pancytopenia in ...
Page xx
... Prophylaxis 95 Primary Familial Thrombocytosis 95 Hemostasis: Developmental Aspects and Rare Congenital Bleeding Disorders 97 Nivedita Dhingra, SP Yadav, Anupam Sachdeva Neonatal Hemostasis 97 Intrinsic Pathway 99 Extrinsic Pathway 100 ...
... Prophylaxis 95 Primary Familial Thrombocytosis 95 Hemostasis: Developmental Aspects and Rare Congenital Bleeding Disorders 97 Nivedita Dhingra, SP Yadav, Anupam Sachdeva Neonatal Hemostasis 97 Intrinsic Pathway 99 Extrinsic Pathway 100 ...
Page xxi
... Prophylactic Therapy 157 Monitoring 157 Adverse Effects, Reversal of Action and Antidote of UHF 157 Heparin-induced Thrombocytopenia 158 Low Molecular Weight Heparin 158 Mechanism of Action 158 Therapeutic Range 158 Dosing 158 Reversal ...
... Prophylactic Therapy 157 Monitoring 157 Adverse Effects, Reversal of Action and Antidote of UHF 157 Heparin-induced Thrombocytopenia 158 Low Molecular Weight Heparin 158 Mechanism of Action 158 Therapeutic Range 158 Dosing 158 Reversal ...
Page 48
You have reached your viewing limit for this book.
You have reached your viewing limit for this book.
Page 53
You have reached your viewing limit for this book.
You have reached your viewing limit for this book.
Contents
Chapter21 | 156 |
Chapter22 | 165 |
Chapter23 | 178 |
Chapter24 | 181 |
Chapter25 | 199 |
Chapter26 | 208 |
Chapter27 | 232 |
Chapter28 | 247 |
Chapter09 | 69 |
Chapter10 | 75 |
Chapter11 | 85 |
Chapter12 | 90 |
Chapter13 | 97 |
Chapter14 | 115 |
Chapter15 | 120 |
Chapter16 | 125 |
Chapter17 | 130 |
Chapter18 | 144 |
Chapter19 | 148 |
Chapter20 | 153 |
Chapter29 | 259 |
Chapter30 | 262 |
Chapter31 | 266 |
Chapter32 | 272 |
Chapter33 | 281 |
Chapter34 | 289 |
Chapter35 | 298 |
Chapter36 | 305 |
Chapter37 | 309 |
Index | 313 |
Other editions - View all
Common terms and phrases
abnormalities acid activity acute adults antibodies anticoagulant antigen aplastic anemia APTT assay associated bleeding blood loss bone marrow transplantation catheter cause chemotherapy child childhood chronic clinical concentration congenital cytopenia decreased defects develop diagnosis disease disorders Disseminated intravascular coagulation donor dose drugs erythrocyte erythropoietin factor VIII ferritin fetal fibrin fibrinogen folate g/dl gene globin granulocytes Haematol hematocrit hematological hemoglobin hemolysis hemolytic anemia hemophilia hemorrhage heparin hepatitis immune increased India infants infection infusion inhibitor intravenous iron deficiency ischemic laboratory leukemia levels liver malignancy mutations myelodysplastic syndrome myeloid neonatal neutropenia newborn normal nutritional occur oral patients Pediatr peripheral plasma platelet platelet count platelet transfusion present preterm prophylaxis protein prothrombin red cell reticulocyte count risk serum severe splenectomy stem cell stroke studies syndrome Table thalassemia therapy thrombin thrombocytopenia thrombocytosis thrombosis tissue treatment usually venous viral virus vitamin